Inflammasome Therapeutics develops therapies targeting degenerative diseases such as Alzheimer's, Parkinson's, and macular degeneration by focusing on the activation of inflammasomes to modulate inflammatory responses. This approach aims to mitigate disease progression and improve patient outcomes through a novel mechanism of action.
Funding
$3.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Degenerative diseases like Alzheimer's, Parkinson's, multiple sclerosis, and macular degeneration lack effective treatments that address the underlying inflammatory processes contributing to disease progression. Current therapies often manage symptoms without targeting the root cause of inflammation.
Solution
Inflammasome Therapeutics is developing a new class of therapies that target the activation of inflammasomes, key components of the innate immune system responsible for triggering inflammatory responses. By modulating inflammasome activation, the company aims to reduce chronic inflammation and slow or reverse the progression of degenerative diseases. This innovative approach seeks to address the underlying pathology of these conditions, offering a potential disease-modifying treatment option. The therapies are designed to intervene in the inflammatory cascade, preventing further damage to affected tissues and improving patient outcomes.
Target Audience
The primary target audience includes patients suffering from degenerative diseases such as Alzheimer's, Parkinson's, multiple sclerosis, and macular degeneration, as well as healthcare providers specializing in these conditions.
Features
- Focus on modulating inflammasome activation to control inflammatory responses.
- Development of therapies for Alzheimer's disease, Parkinson's disease, multiple sclerosis, and macular degeneration.
- Novel mechanism of action targeting the root cause of inflammation in degenerative diseases.